Abstract
Glicentin, the main component of enteroglucagon, has trophic effects on intestinal mucosa. It may also have an inhibitory effect on extraintestinal invasion of enteric bacteria. We have established an in vitro bioassay system for determining the effects of recombinant human glicentin on bacterial internalization by confluent enterocytes. An INT-407 cell line was serum-deprived for 2 days and was then treated on transwell filters for 24 h with a medium containing one of the following: glicentin 100 ng–1 μg/ml, glucagons-like peptide-2 (GLP-2) 1 μg/ml, 10% fetal bovine serum (FCS), or without any growth factors. Pure cultures of Salmonella enteritidis, Escherichia coli, and Enterococcus faecalis were introduced to the upper chambers of the filter units. Following 2 h of incubation the numbers of bacteria in the lower chambers were measured. Pretreatment of enterocytes with glicentin inhibited bacterial internalization compared to untreated or GLP-2 enterocytes. Glicentin was associated with inhibition of enterocyte internalization of enteric bacteria by a mechanism that might be related to the integrity of the enterocyte adhesive junctions and tight junctions and to the production of sIgA. Glicentin seems to have a function as a barrier-sustaining agent that inhibits extraintestinal invasion of enteric bacteria.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Sagor GR, Ghatel MA, Al-Mukhtar MYT, Wright NA, Bloom SR (1983) Evidence for a humoral mechanism after small intestinal resection. Gastroenterol 84:902–906
Jenkins AP, Thomson RPH (1994) Mechanism of small intestinal adaptation. Dig Dis 12:15–27
Chen Y, Rabinovitch PS (1989) Platelet-derived growth factor, epidermal growth factor, and insulin-like growth factor I regulate specific cell-cycle parameters of human diploid fibroblasts in serum-free culture. J Cell Physol 140:59–67
Matsuda M, Okabe I (1991) Effects of EGF administration during intestinal adaptation in the rat after massive enterectomy. J Nihon Univ Med Assoc 50:869–877
Duncan MD, Korman LY, Bass BL (1994) Epidermal growth factor primes intestinal epithelial cells for proliferative effect of insulin-like growth factor I. Dig Dis Sci 39:2197–2201
Okajima T, Nakamura K, Zhang H, Ling N, Tanabe T, Yasuda T, Rosenfeld RG (1992) Sensitive colorimetric bioassays for insulin-like growth factor (IGF) stimulation of cell proliferation and glucose consumption: use in studies of IGF analogs. Endocrinology 130:2201–2212
Gleeson MH, Bloom SR, Polak KH, Dowling RH (1971) Endocrine tumor in kidney affecting small bowel structure, motility, and absorptive function. Gut 12:773–782
Bloom SR (1972) An enteroglucagon tumor. Gut 13:520–523
Sundby F, Jacobsen H, Moody AJ (1976) Purification and characterization of protein from porcine gut with glucagonlike immunoreactivity. Horm Metab Res 8:366–371
Ottenthal O, Batt RM, Carter MW, Bloom SR (1982) Stimulation of DNA synthesis in cultured small intestine by partially purified enteroglucagon. Regul Pept 3:84
Katsuta T (1986) Role of glicentin in intestinal adaptation to massive small bowel resection. J Nihon Univ Med Assoc 45:237–247
Litvak DA, Hellmich MR, Evers BM, Banker NA, Townsend CM (1998) Glucagon-like peptide 2 is a potent growth factor for small intestine and colon. J Gastrointest Surg 2:146–150
Ravassola M, Siperstein A, Moody AJ, Sundby F, Jacobsen H, Orci L (1979) Glicentin immunoreactive cell: their relationship to glucagon-producing cells. Endocrinology 105:499–507
Imai S, Sasaki K, Satoh T, Oomori T, Iwata N, Yanaihara N, Natori Y (1996) Production of human glicentin in Escherichia Coli. Biomed Res 17:279–285
Chiba M, Sanada Y, Tsunoda Y, Yoshizawa Y, Nemoto H, Okamatsu T (1998) Proliferative effects of glicentin on human intestinal epithelial cells. J Jpn Soc Pediatr Surg 34:1155–1161
Chiba M, Sanada Y, Tsunoda Y, Yoshizawa Y, Nemoto H, Okamatsu T (2000) Proliferative effects of glicentin on human intestinal epithelial cells. Jpn J Pediatr Surg 32:147–151
Chiba M, Yoshizawa Y, Sanada Y, Yamaguchi M (2003) Proliferative effects of glicentin on human intestinal epithelial cells. Showa Univ J Med Sci 14:223–231
Chiba M, Sanada Y, Yoshizawa Y, Kawano S, Murofushi M, Hirai H (2005) Glicentin inhibits internalization of enteric bacteria in cultured INT-407 enterocytes. J Jpn Soc Pediatr Surg 41:636–642
Henle G, Deinhardt F (1957) The establishment of strains of human cells in tissue culture. J Immunol 17:54–59
Tobias AO, Ben DT (1996) Uptake pathways of clinical isolates of proteus mirabilis into human epithelial cell lines. Microb Pathog 21:1–16
Gronroos E, Thodeti CK, Sjolander A (1998) Leukotriene D4 induces a rapid increase in camp in the human epithelial cell line, INT 407: a potential role for this signal in the regulation of calcium influx through the plasma membrane. Cell Calcium 24:9–16
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Chiba, M., Sanada, Y., Kawano, S. et al. Glicentin inhibits internalization of enteric bacteria by cultured INT-407 enterocytes. Pediatr Surg Int 23, 551–554 (2007). https://doi.org/10.1007/s00383-007-1895-9
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00383-007-1895-9